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Abstract 
 
 Human cytomegalovirus (HCMV), a member of the Betaherpesvirinae sub-family 
of Herpesviridae family, is a widespread pathogen that infects a majority of the world’s 
population by early adulthood.  In individuals whose immune systems are immature or 
weakened, HCMV is a significant pathogen causing morbidity and mortality.  There is no 
effective vaccine and only limited antiviral treatments against HCMV infection to date.  
A possible target for novel antiviral treatments is the HCMV proteins that localize to the 
tegument of the virion, since they play important roles in all stages of the viral life cycle, 
including, viral entry, gene expression, immune evasion, assembly, and egress.  The most 
likely tegument protein candidates are pp65 (immune evasion), pp71 (gene expression), 
and pp150 and pp28 (assembly and egress). Although the subcellular localization of these 
proteins has been identified during HCMV infections in vitro, their localization patterns 
have not been elucidated when each protein is expressed individually in living cells. 
 The objective of this research was to determine the subcellular localization of the 
tegument proteins pp65, pp71, pp150, and pp28 as fusions to one of several fluorescent 
proteins.  Since these tegument proteins play pivotal roles in several stages of the viral 
life cycle, knowledge of where and the mechanism of how these proteins localize upon 
release could result in a better understanding of their function during a lytic infection as 
well as assist in the development of an effective, novel antiviral treatment.  The 
localization patterns were determined via fluorescent confocal microscopy in 
paraformaldehyde fixed cell and live-cell imaging experiments after transfection of the 
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fusion protein plasmids.  It was shown that the localization of each tegument protein was 
independent of each other, and that live-cell imaging experiments gave better results than 
fixed cell imaging experiments.  Furthermore, the subcellular localization of pp71 and 
pp150 (nucleus), and pp28 (cytoplasm) were identical to what occurs in a typical HCMV 
lytic infection, suggesting a strong correlation between localization and function.  
However, pp65, the major tegument protein involved in immune evasion, did not show its 
characteristic nuclear localization pattern as reported previously.  Instead it has been seen 
to localize to the cytoplasm of the cell.  This is interesting for two reasons.  One is that 
the localization patterns of the tegument proteins are highly correlated with their function 
during the lytic cycle of HCMV infections.  If pp65 doesn’t localize to the nucleus, the 
lytic cycle will not develop.  The second is that pp65 is known to have a bipartite nuclear 
localization signal.  Therefore, it was hypothesized that there is another molecule in the 
HCMV virion necessary to localize pp65 into the nucleus.  Potentially, the nuclear 
localization signal of pp65 is within an inaccessible region to nuclear transport 
molecules.  A mechanism could involve the other molecule within the HCMV virion 
binding to pp65, inducing a conformational change that results in the nuclear localization 
signal becoming accessible and recognizable to nuclear transport molecules and its 
subsequent localization to the nucleus.  Thus, a novel antiviral treatment could target the 
other molecule in the HCMV virion, and prevent pp65 from getting into the nucleus; 
subsequently inhibiting the HCMV lytic infection.  This research has increased our 
understanding of HCMV lytic infections as well as identifies a potential target for a 
novel, antiviral treatment. 
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Introduction 
 
Human Cytomegalovirus Significance 
 
 Human cytomegalovirus (HCMV) is a member of the Betaherpesvirinae sub-
family of Herpesviridae.  It is a widespread pathogen that infects a majority of the 
world’s population by early adulthood (1).  In fact, by the age of 40, between 50 and 85% 
of adults are infected by HCMV (2).  The virus establishes a life-long infection with 
some cells being latently infected, a state where the virus has the ability to lie dormant 
within a cell, while others are persistently infected, where the infection cannot be cleared 
from an organism and there is intermittent shedding of infectious virions (3).  
Immunocompetent individuals, who can develop a strong immune response, typically 
display no symptoms of infection (4).  However, in individuals whose immune systems 
are immature or weakened, such as organ transplant and AIDS patients, HCMV is a 
significant pathogen causing morbidity and mortality (5).  Symptoms in these individuals 
typically consist of spiking fever, leucopenia (decrease in white blood cells), malaise, 
hepatitis, pneumonia, gastrointestinal disease and/or retinitis (inflammation of the retina) 
(4).  HCMV is also responsible for approximately 8% of infectious mononucleosis cases 
(6) and is the leading viral cause of birth defects often causing deafness and mental 
retardation in the fetus if a woman is infected during pregnancy (7).   
HCMV has been implicated in playing a role in inflammatory and proliferative 
diseases, including certain cardiovascular diseases and cancer (8).  Epidemiological and 
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pathological studies have espoused a strong link between HCMV and atherosclerosis (8).  
Several mechanisms have been proposed in which HCMV could influence the 
development of athersclerotic vascular abnormalities (9).  A proposed role of HCMV in 
the pathogenesis of atherosclerosis involves the reactivation of a latent HCMV infection 
followed by virus-induced enhancement of vascular inflammation and damage through 
smooth cell proliferation, uptake of low-density lipoproteins by smooth cells, neointimal 
formation (thickened arterial layer via cell migration and proliferation), and narrowing of 
the vessel lumen (9). 
 There is no effective vaccine against HCMV, and drugs that inhibit viral 
replication exist but are ineffective due to high toxicity, low bioavailability, and the 
development of drug-resistant virus strains (8,10).  The primary antiviral agents used to 
treat HCMV infections in patients with an impaired immune system are ganciclovir, 
foscarnet, and cidofovir (9).  These drugs have improved the survival and quality of life 
of immunocompromised individuals suffering from HCMV, but they are far from ideal 
due to major hematologic, renal, and neutropenia toxicity (9).  Therefore, the lack of an 
effective treatment for HCMV infections, especially in immunocompromised individuals, 
has resulted in intense study for the identification of proteins and processes that could be 
targeted by novel antiviral treatments (8). 
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Human Cytomegalovirus Structure and Life Cycle 
 
 HCMV has the prototypical herpesvirus virion structure (Figure 1) and the 
replication cycle has a well controlled cascade of gene expression (9).  The virion has an 
icosahedral protein capsid that contains the 235-kb double-stranded DNA.  The capsid is 
surrounded by a proteinaceous tegument and an outer lipid envelope (1).  Virions gain 
entry into a cell through a membrane fusion event involving the outer membrane of the 
cell and glycoproteins on the lipid envelope of virions.  Once the fusion of these two 
membranes occurs, the DNA-containing protein capsid and the tegument proteins are 
released into the cell (11).   
The gene expression pattern follows a similar cascade as used by other 
herpesviruses as reviewed in Kalejta (2008) (12).  During the lytic infection, viral 
immediate-early genes are expressed (8).  The expression of these genes results in the 
production of viral immediate-early proteins that modulate the host cell environment and 
stimulate the expression of viral early genes (1).  The viral-immediate early genes 
produce proteins that are responsible for replicating the double-stranded viral genomic 
DNA; after DNA replication, these immediate-early genes turn on the expression of viral 
late genes (1).  The viral late proteins are mainly structural components of the virion that 
assist in the assembly and egress of newly formed viral particles (1).  Immediate-early 
genes in HCMV can be silenced in certain cell types upon infection though, which results 
in a latent infection (13).  A latent infection is characterized by the minimization of viral 
gene expression and the inhibition of the assembly and egress of new viral progeny (11).  
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Latent infections can reactivate into a lytic infection upon certain environmental cues, 
which causes disease and allows viral spread (1, 12). 
 
 
Figure 1 A cartoon depicting the structure of the HCMV virion.  (Image obtained from 
(http://www.virology.net/big_virology/bvdnaherpes.html) courtesy of Dr.  Marko 
Reschke in Marburg, Germany).   
 
 HCMV infected cells also produce noninfectious enveloped particles and dense 
bodies in addition to infectious virions as reviewed in Kalejta (2008) (12).  Noninfectious 
enveloped particles are similar to infectious virions in that they contain a nearly an 
identical assortment of envelope, tegument, and capsid proteins, but they lack the double-
stranded viral genome within the icosahedral capsid (14).  Dense bodies on the other 
hand are enveloped tegument proteins that lack capsids and are primarily composed of 
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the viral pp65 protein (14).  The significance of the noninfectious enveloped particles and 
dense bodies is not known in wild-type strains of HCMV (14). 
 
Tegument Structure and Function 
 
 A possible target for novel antiviral treatments is the HCMV proteins that localize 
to the tegument.  As mentioned, the tegument in HCMV is located between the outer 
lipid membrane and the icosahedral protein capsid, which contains the viral genomic 
double-stranded DNA (11).  The tegument is generally thought to be unstructured and 
amorphous in nature although some structuring is seen with the binding of tegument 
proteins to the protein capsid (15).  The tegument proteins comprise more than half of the 
total proteins found within infectious virions (16).  Tegument proteins are 
phosphorylated, but the significance of this and other posttranslational modifications to 
these proteins remains largely unexplored (11).  A common sequence to direct proteins 
into the tegument has not been identified through either experimental or bioinformatic 
approaches (17).  The process of assembling the viral tegument upon viral egress and 
disassembly upon viral entry into cells is largely unknown (17).  However as reviewed in 
Kalejta (2008), phosphorylation, subcellular localization to the assembly site, and 
interaction with capsids or the cytoplasmic tails of envelope proteins, likely facilitate the 
incorporation of proteins into the HCMV tegument (12). 
 As mentioned above, virions gain entry into a cell through a membrane fusion 
event involving the outer membrane of the cell and the lipid membrane of virions.  The 
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entry of the tegument proteins as well as the DNA-containing protein capsid upon viral 
entry occurs after the fusion of these two membranes (11).  Upon release into the 
cytoplasm, tegument proteins become  functionally active, where they play important 
roles in all stages of the viral life cycle, including, viral entry, gene expression, immune 
evasion, assembly, and egress (1, 11).  There are several tegument proteins that are of 
particular interest due to the role (elucidated below) that they play in the HCMV 
replication cycle, including pp65, pp71, pp150, and pp28. 
 
Tegument Protein pp65 
 
 Pp65 is the most abundant tegument protein and the major constituent of 
extracellular virus particles (18).  However, pp65 is not essential for the production of 
new infectious virus particles as evidenced in strains that lack the pp65 gene (18) which 
can still replicate in culture.  Pp65 is the major tegument protein responsible for 
modulating/evading the host cell immune response during HCMV infections (19).  As 
reviewed in Kalejta (2008), pp65 is implicated in counteracting both innate and adaptive 
immune responses during HCMV infections (12).   pp65’s role in immune evasion is 
largely attributable to its targeting of both humoral and cellular immunity as well as 
serving as the dominant target antigen of cytotoxic T lymphocytes (19).  It has been 
demonstrated that pp65 not only prevents immediate-early proteins from being 
recognized by components of the immune system, but it also inhibits the synthesis of the 
various components involved in the host cell’s immune response (20).  One of the ways 
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in which pp65 counteracts adaptive immunity is through its enzymatic kinase activity 
(21).  It was shown that pp65 mediates the phosphorylation of viral immediate-early 
proteins, which blocks their presentation to the major histocompatibility complex class I 
molecules (22).  The kinase activity of pp65 has also been implicated in causing the 
degradation of the alpha chain in the major histocompatibility class II cell surface 
receptor, HLA-DR, via an accumulation of HLA class II molecules in the lysosome (20).  
Furthermore, several studies have presented evidence that pp65 is involved in mediating 
a decrease in the expression of major histocompatibility complex class II molecules (20).  
This is significant in that major histocompatibility complex class I and II molecules are 
responsible for lymphocyte recognition and antigen presentation with class I molecules 
presenting to cytotoxic T lymphocytes CD8+ and class II molecules to helper T 
lymphocytes CD4+ (20). 
 Another pivotal role that pp65 has in immune evasion during HCMV infections is 
through the inhibition of natural killer cell cytotoxicity (23).  Specifically, it was shown 
that pp65 can act as an antagonistic ligand that can bind to the NKp30 activating receptor 
to protect the killing of infected cells as well as interfere with the ability of NKp30 to 
cross-talk between other natural killer cells and dendritic cells (23,24) 
 Finally, pp65 has been shown to attenuate the interferon response (25).  It is 
thought that pp65 is involved in down modulating beta interferon and a number of 
chemokines, which is based on the observation of an elevated expression of interferon 
genes in infections with a strain lacking the pp65 protein (25). 
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 Thus, the role that pp65 has in immune evasion in HCMV infections is to prevent 
infected cells from being destroyed by the immune system.  Furthermore, it has been 
shown to protect infected cells from the immune response by binding to components of 
the immune system, thereby inhibiting their activation (24). 
 
Tegument Protein pp71 
 
 Pp71, by comparison, plays an important role in the activation of immediate-early 
gene expression at the start of the lytic replication cycle (26).  Although this protein is not 
absolutely essential, it is necessary for efficient viral replication as reviewed in Kalejta 
(2008) (12).  A proposed mechanism for how pp71 activates viral gene expression is by 
neutralizing the effects of the cellular Daxx protein, which is recruited to promoters by 
DNA-binding transcription factors, resulting in the repression of transcription (27).  Pp71 
can bind to two inherent domains on Daxx and induce its proteasomal degradation (28).  
Additionally, it was demonstrated that pp71 increases the infectivity of viral genomic 
DNA when transfected into cultured cells (29). 
 Recently though, pp71 has also been implicated in immune evasion, similar to 
pp65, by disrupting the major cell surface expression of components of the immune 
response (30).  Specifically, pp71 appears to target the cell surface receptors of major 
histocompatibility complex class I proteins by slowing their intracellular transport (30).  
This limits the ability of infected cells to display viral antigens to the immune system and 
prevents recognition by cytotoxic T lymphocytes. 
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Tegument Proteins pp150 and pp28 
 
 Pp150 and pp28 are highly immunogenic and play roles in the assembly and 
egress of virus particles.  Both of these tegument proteins play very similar roles, but 
have some distinct functions.  pp150, the second most abundant tegument protein behind 
pp65, is necessary to incorporate nucleocapsids into virus particles (16).  Pp150 is 
essential for maintaining the stability of the cytoplasmic capsids and directing their 
movement (1,31).   
 Pp150 also plays a role in the reorganization of the cytoplasmic assembly 
compartment during virion assembly (31).  The process of virion assembly in HCMV has 
been reviewed in Kalejta (2008) (12).  After the viral genome and late genes are 
expressed, capsid formation and DNA packaging into the preformed capsids begins to 
occur in the nucleus.  Capsids acquire a primary envelope when they bud through the 
inner nuclear membrane into the perinuclear space, which they lose upon budding 
through the outer nuclear membrane into the cytoplasm.  The capsids then bud into Golgi 
apparatus-derived vesicles and obtain their final envelope.  When these vesicles fuse with 
the cell membrane, the enveloped virion is released.  Pp28 is largely responsible for the 
cytoplasmic envelopment of tegument proteins and capsids in HCMV during the 
assembly and egress process (12, 32). 
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Tegument Protein Subcellular Localization 
 
 As illustrated, the tegument proteins play important roles in all stages of the viral 
life cycle, including, viral entry, gene expression, immune evasion, assembly, and egress 
(11).  However, the subcellular localization of the tegument proteins after their release 
into the cytoplasm at the beginning stage of infection has not been fully elucidated.  This 
is especially true for the localization of the tegument proteins when they are expressed 
individually or in combinations without the rest of the HCMV virion.  Furthermore, the 
structure of the tegument itself is not known, and the process of assembling the tegument 
upon viral egress, as well as the disassembly of the tegument upon viral entry into cells, 
is poorly understood (17).  Therefore, the objective of this research was to determine the 
subcellular localization of the primary tegument proteins pp65, pp71, pp150, and pp28, 
after transfection of plasmid DNA expressing each protein as a fluorescent protein fusion.  
Since these tegument proteins play pivotal roles in several stages of the viral life cycle, 
knowledge of where and the mechanism of how these proteins localize upon release 
could be fundamental in the development of effective, novel antiviral treatments for this 
widespread human pathogen, which would have great therapeutic value for 
immunocompromised individuals. 
 When HCMV virions fuse with the membrane of host cells, some tegument 
proteins remain in the cytoplasm, while others migrate to the nucleus of the cell (33).  
Other tegument proteins will remain tightly associated to the nucleocapsids, and mediate 
their delivery to the nuclear pore complex via the microtubule assembly as reviewed in 
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Kalejta (2008) (12).  Several tegument proteins though will have a specific localization 
within the cell depending on the stage of the lytic cycle. 
 In the early stage of infection, pp65 tends to independently migrate to the nucleoli 
of the cell (34).  The localization of pp65 to the nucleoli suggests a functional 
relationship between the localization of pp65 and the development of the lytic cycle of 
HCMV (34).  However, pp65 begins to migrate to the cytoplasm 48 hours into the lytic 
cycle with nuclear pore complex becoming devoid of the protein (35).  This migration 
appears to be mediated by cyclin-dependent kinase activity and a Crm1 exporter (36). 
 pp71, by comparison, has a similar localization pattern as pp65 during the lytic 
cycle of HCMV infections.  The subcellular localization of pp71 upon viral entry is to the 
nucleus of the host cell (33).  This localization appears to be essential for the initiation of 
either a lytic or latent infection (37).  During the later stages of infection, some pp71 
appears to localize subcellularly to both the nucleus and the cytoplasm (38). 
 Unlike the subcellular localization of pp65 and pp71, which appears to be 
dependent on the stage of the lytic life cycle of HCMV, the localization of pp150 has not 
been well-defined.  Some studies have suggested that the subcellular localization of 
pp150 initially when it associates with the viral nucleocapsids is to the nucleus, while 
other studies suggest that it is to the cytoplasm (39,40).  The subcellular localization of 
pp28 on the other hand appears to be to specific cytoplasmic compartments (41).  This 
localization appears to be essential for the production of viral progeny, since it is 
localized at the site of final envelopment (41). 
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Fluorescence Proteins as Localization Tags 
 
 The development of fluorescent protein molecules to act as localization tags for 
subcellular components has revolutionized the biomedical sciences (42).  The first 
instance occurred when Aequorea victoria jellyfish wild-type green fluorescent protein 
(GFP) was used to highlight sensory neurons in the nematode (43).  Fluorescence is such 
a powerful tool in that it allows one to distinguish and identify cellular components that 
are either too small or lack little contrast with the background with traditional microscopy 
techniques.  The wild-type green fluorescent protein molecule was modified to yield 
different variants due to its complex emission spectrum (44).  Nonetheless, extensive 
research has occurred in recent years to produce new and improved fluorescent tags that 
are brighter, cover a broad spectral range, and also exhibit enhanced photostability, 
reduced oligomerization, pH insensitivity, and faster maturation rates (42). 
 Due to the success of various fluorescent protein molecules being used as tags to 
assess the subcellular localization and of many cellular and viral proteins, several distinct 
fluorescent protein molecules were utilized in this experiment to identify the subcellular 
localization of HCMV tegument proteins pp65, pp71, pp150, and pp28, respectively (44).  
The fluorescent tegument protein fusions were constructed previously by inserting the 
open reading frame of each tegument protein into a plasmid containing a fluorescence 
gene so that the two protein coding reagions are in-frame and produce a fusion protein 
(Pizzorno et al, unpublished data).  After the plasmid and tegument proteins undergo 
restriction digests, the resultant sticky ends fuse to form the fluorescently labeled 
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tegument protein plasmid.  The fluorescent tegument protein fusions are identified by 
transforming them into bacterial cells on a plate containing a specific antibiotic.  Since 
the plasmid contains the antibiotic resistance gene, the colonies that are transformed with 
the fusion plasmid are able to survive on the plate.  The fusion plasmids are then isolated 
from the bacterial colonies that were transformed. 
 In total, three variant fluorescent proteins (Cyan-blue, RFP (DsRed2)-red, GFP-
green) were used to tag and label the tegument proteins.  Pp65 was tagged with Cyan, 
pp71 with RFP, and pp150 and pp28 with GFP.  The characterization of each fluorescent 
protein molecule can be seen in Table 1.  Additionally, the location of the fluorescent 
tags on each protein can be seen in the appendix. 
 
Table 1 Characterization of the fluorescent molecules used to tag HCMV tegument 
proteins pp65, pp71, pp150, and pp28. 
Fluorescent 
Molecule 
Tegument 
Protein(s) 
Labeled 
Excitation 
Peak (nm) 
Emission 
Peak (nm) 
Brightness Photostability pKa 
Cyan pp65 433/445 475/503 13 64 4.7 
RFP pp71 584 607 12.5 8.7 4.5 
GFP pp150 
and pp28 
488 507 34 174 6.0 
 
 
Experimental Outline and Objectives 
 
 As mentioned, the objectives of this study were to identify the subcellular 
localization of HCMV tegument proteins pp65, pp71, pp150, and pp28 to understand 
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how these proteins interact with the cell and function during the lytic cycle of HCMV 
infections.  Additionally, identification of the HCMV tegument protein localization 
patterns could assist in the development of a better targeted effective, novel antiviral 
treatment of HCMV infections, especially in immunocompromised individuals.  This was 
accomplished through the use of cell culture and microscopy techniques.  The tegument 
proteins of interest were first fused to a fluorescence protein (Cyan-blue, RFP-red, GFP-
green), as described to in the previous section, that will emit/fluoresce when exposed to a 
certain wavelength of light.  The DNA that encodes these modified tegument proteins 
were then transfected into an established human cell lines (HeLa cells).  Confocal 
microscopy, which is an imaging technique that is used to increase the optical resolution 
and contrast of photographs obtained through a microscope, was then utilized to 
determine the subcellular localization of each tegument protein within the transfected 
cells by noting where the Cyan, RFP, or GFP molecule fluoresces to reconstruct three-
dimensional structures of the obtained images.  Additionally, the images obtained from 
the fluorescence tags were compared and overlaid with images obtained by concurrently 
staining with DAPI or Hoechst 33342, which are fluorescent stains that have a high 
affinity for DNA.  Since the DNA is located within the nucleus of cells, this allowed for a 
definitive identification of where these tegument proteins localize subcellularly in 
transfected cells. 
 There were three distinct series of steps in determining the localization of the 
tegument proteins.  The localization of the tegument proteins were first identified in fixed 
cells that were transfected with plasmids containing the tegument proteins of interest.  
17 
 
Since the localization of each protein may be affected by the presence or absence of other 
tegument proteins, a series of transfections occurred, including the tegument proteins by 
themselves and a combination of the different tegument proteins of interest.  Since we 
have three different fluorescence tags, we were able to observe the localization of three 
tegument proteins in a single cell.  The localization patterns in the fixed cells were then 
compared to the same series of transfections in live cells to acquire more accurate 
observations of the localization patterns as well as to rule out the possibility that artifacts 
of the fixation process may have affected the subcellular localization patterns of the 
tegument proteins. 
 
Hypothesis 
 
 It was hypothesized that each of the tegument proteins, pp65, pp71, pp150, and 
pp28, would display subcellular localization patterns similar to what is seen in natural 
HCMV infections in both fixed and live-cell imaging.  Furthermore, it was expected that 
the subcellular localization of each HCMV tegument protein would have display a strong 
correlation between its known function during natural HCMV infections.  It was 
hypothesized that pp65 would localize subcellularly to the nucleus as seen in the early 
stages of a natural HCMV infection.  However, it was expected that very little pp65 
would be found in the cytoplasm, since only the initial stage of the viral life cycle was 
mimicked during the transfection procedure.  Pp71 was also hypothesized to localize 
subcellularly to the nucleus as seen in natural HCMV infections due to its necessity in 
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efficient viral replication.  Pp150 on the other was expected to be in either the nucleus, 
cytoplasm, or both due to its poorly defined localization pattern within natural HCMV 
infections.  Nonetheless, it was felt that pp150 would localize more to the nucleus than 
the cytoplasm.  Finally, it was anticipated that pp28 would localize subcellularly to 
various cytoplasmic compartments within the cell as seen in natural HCMV infections 
due to its essential role in the production of viral progeny at the site of final envelopment, 
which occurs in the cytoplasm of the cell.  It was also hypothesized that the localization 
patterns of some of the tegument proteins could be affected via co-transfection with other 
tegument proteins, since previous data in the laboratory has suggested that the 
localization pattern of pp150 is dependent upon whether or not pp71 is present. 
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Materials and Methods 
 
Cell Culture 
 
 HeLa cells were grown in 1x Dulbecco's Modified Eagle Medium (DMEM) 
(Invitrogen) supplemented with 10% fetal calf serum (FCS), 100x Glutamax (Invitrogen), 
and the antibiotics penicillin and streptomycin (PS).  They were maintained by 
subculturing at 1:20 ratio unless otherwise noted after reaching 80-85% confluency.  The 
cells were incubated at 37°C and 5% carbon dioxide. 
 
Transfection of Plasmid DNA into Cells 
 
 Prior to transfection, 5x10
4
 HeLa cells were cultured in each well of a 24 well 
culture vessel containing sterile glass coverslips in 1 mL DMEM/10% 
FCS/PS(Invitrogen).  The HeLa cells were transfected 24 hours later using 
Lipofectamine
TM
 2000 (Invitrogen) according to the manufacturer’s protocol.  Tegument 
protein DNA (0.8 μg) per well was diluted in 50 μL of DMEM without FCS and 
antibiotic and mixed.  The plasmid DNA that was transfected expressed either pp65, 
pp71, pp150, or pp28 fused to a fluorescent protein. Each plasmid was transfected alone 
or in combination with one or two additional tegument protein plasmids.   
 Lipofectamine
TM
 2000 (2.0 μL) per well was diluted in 50 μL of DMEM without 
FCS and antibiotic and incubated for 5 minutes at room temperature.  After the five 
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minute incubation period the diluted tegument protein DNA and Lipofectamine
TM
 2000 
were mixed and incubated for 20 minutes at room temperature.  Following the 20 minute 
incubation period, the 100 μL DNA and LipofectamineTM 2000 complexes were added to 
each well and mixed.  The transfected HeLa cells were then incubated at 37°C with 5% 
carbon dioxide for 12 hours.  After the incubation period, the growth media in each well 
was changed, which was followed by another 24 hour incubation period. 
 Following the 24 hour incubation period, the growth media was removed and the 
cells were washed twice in 1x phosphate buffered saline (PBS).  The HeLa cells were 
then fixed with 4% paraformaldehyde in 1x PBS for 10 minutes at room temperature.  
The paraformaldehyde was then removed, and the cells were washed three times in 1x 
Phosphate Buffered Saline Tween-20 (1x PBS, 0.1% Triton-X 100, 0.05% Tween 20).  
The cells were washed an additional time in 1x PBS.  After the wash, the cells were 
placed in 1x PBS. 
 The coverslips in each well were removed and dipped three times in dH2O.  They 
were then placed on a slide in a drop of the DAPI (Vector Laboratories) mounting media 
and stored at room temperature in the dark overnight.  The slides were then stored at  
-20°C until imaged with a Leica SP5 confocal microscope.  
 
HCMV Live-Cell Tegument Protein Transfection 
 
 Prior to transfection, 5x10
4
 cells were transferred into glass bottom culture dishes 
with coverslips with a thickness of 0.16-0.19 mm in 1 mL DMEM/10% FCS/PS  
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(Invitrogen).  The HeLa cells were then transfected 24 hours later using Lipofectamine
TM
 
2000 as described above.  The transfected HeLa cells were then incubated at 37°C with 
5% carbon dioxide for 24 hours. 
 Following the 24 hour incubation period, 0.9 mL of the HeLa cell growth media 
was removed.  The HeLa cells were then either imaged with a Leica SP5 confocal 
microscope or incubated with 1 μg/mL of the nuclear stain Hoechst 33342 (Thermo 
Scientific) for five minutes at room temperature.  The cells that were incubated for five 
minutes with the Hoechst 33342 nuclear stain were then imaged with a Leica SP5 
confocal microscope. 
 
Confocal Microscopy 
 
 Fixed cell- and live-cell imaging was performed using a Leica SP5 confocal laser 
scanning microscope.  Confocal image scans were processed using the LAS AF software. 
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Results 
 
Tegument Protein Subcellular Localization in Paraformaldehyde Fixed Cells with DAPI 
Stain 
 
 The subcellular localization of HCMV tegument proteins pp65, pp71, pp150, and 
pp28 was first determined in HeLa cells that had been fixed with paraformaldehyde.  
Plasmids expressing various versions of the tegument proteins fused to a fluorescent 
protein had been constructed previously (pp65-CFP, pp71-RFP, pp150 and pp28-GFP) 
and the size of the fusion protein has been confirmed using Western blot (M. Pizzorno, 
personal communication).  These expression plasmids were transfected into HeLa cells 
and the cells were fixed 36 hours post-transfection with 4% paraformaldehyde.  The fixed 
cells were then mounted with a DAPI (nuclear stain) containing mounting medium, 
which binds to DNA and acts as a nuclear stain, and imaged with confocal microscopy. 
 The subcellular localization of pp65, pp71, and pp150 when expressed together in 
HeLa cells that were then fixed with paraformaldehyde can be seen in Figure 2.  Based 
on the location of the nucleus as identified by the DAPI nuclear stain in Figure 2A, it 
appears that both pp150 and pp71 (Figure 2C/D respectively) appear to localize to the 
nucleus of the cell.  Furthermore, it appears that pp150 and pp71 have very similar if 
almost identical localization patterns, which could suggest co-localization of the proteins 
to the nucleus of the cell.  Pp65 by comparison displays a unique pattern of subcellular 
localization in that it has a sparse localization pattern (Figure 2B).  It appears that pp65 is 
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potentially localized to the nucleus although it appears that its localization is just outside 
the nucleus in the cytoplasm. 
 Likewise, the composite image in Figure 3 consisting of the overlaid channels of 
Figure 2 supports the initial analysis that pp150 and pp71 appear to localize to the 
nucleus.  It is more difficult to determine if in fact pp65 localizes to the cytoplasm in the 
composite image, since the nuclear signal is very strong, while the pp65 signal is weak 
and sparse.  Furthermore, the nuclear signal may be confounded by DAPI’s potential 
affinity for RNA.  However, if one focuses only on the fluorescently labeled tegument 
proteins in Figure 2 B-D, pp65 does appear to localize to the cytoplasm of the cell. 
 This localization pattern of the tegument proteins pp65, pp150, and pp71 when all 
three are expressed together (Figures 2 and 3) is supported when HeLa cells were 
transfected with two of the three tegument proteins plasmids (Figures 4-9) as well as in 
HeLa cells transfected with only a single tegument protein plasmid (data not shown).  
This also refutes any possibility of one of the tegument proteins affecting the subcellular 
localization of another (See Discussion).  It can be seen that pp150 and pp71 definitively 
localize to the nucleus with very similar patterns of localization.  Nonetheless, the 
localization pattern of pp65 is still quite complicated although it still does appear that 
pp65 could potentially localize to the cytoplasm, since it generally is located near the 
very edge of the nucleus.  It is somewhat surprising that the nucleus doesn’t have a 
distinct structure in a majority of these images although it could be attributable to 
artifacts of the fixation or procedure or DAPI mounting media.  Another area of concern 
is that the interior of the nucleus remains unstained in several of the images although this 
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is also likely attributable to artifacts in the staining procedure (See Discussion for further 
explanation). 
 The subcellular localization of pp28, when co-expressed with pp65 and pp71, was 
determined by confocal microscopy in transfected and paraformaldehyde fixed HeLa 
cells (Figure 10).  Similar to the previous images (Figure 2 and 3); this image also suffers 
from likely artifacts from the fixation procedure.  DAPI could also potentially bind with a 
lower affinity to RNA in the cytoplasm of the cell, making the location of the nucleus 
more difficult to discern.  It appears that there are actually two different nuclei based on 
the localization of pp65 (Figure 10B).  It appears that a lot of the signal in the DAPI, 
pp28, and pp71 confocal scans (Figure 10 A,C,D respectively) could be affected by 
artifacts of the DAPI staining procedure.  Potentially this could have resulted from the 
cell lysing during the fixation process.  Nonetheless, it is difficult to say where pp28 and 
pp71 localize in Figure 10.  The composite image in Figure 11 supports the difficulty in 
determining the subcellular localization of the tegument proteins in Figure 10.  Similar 
results were noted when pp28 was transfected alone in HeLa cells (data not shown). 
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Figure 2 Subcellular localization of CFP-pp65, GFP-pp150, and RFP-pp71 in HeLa cells 
fixed with paraformaldehyde and stained with the nuclear stain DAPI; A- DAPI Stain; B- 
CFP-pp65; C- GFP-pp150; D- RFP-pp71. 
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Figure 3 Subcellular localization composite of CFP-pp65, GFP-pp150, and RFP-pp71 in 
HeLa cells fixed with paraformaldehyde and stained with the nuclear stain DAPI. 
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Figure 4 Subcellular localization of CFP-pp65 and RFP-pp71 in HeLa cells fixed with 
paraformaldehyde and stained with the nuclear stain DAPI; A- DAPI Stain; B- CFP-
pp65; C- RFP-pp71. 
 
Figure 5 Subcellular localization composite of CFP-pp65 and RFP-pp71 in HeLa cells 
fixed with paraformaldehyde and stained with the nuclear stain DAPI. 
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Figure 6 Subcellular localization of CFP-pp65 and GFP-pp150 in HeLa cells fixed with 
paraformaldehyde and stained with the nuclear stain DAPI; A- DAPI Stain; B- CFP-
pp65; C- GFP-pp150. 
 
Figure 7 Subcellular localization composite of CFP-pp65 and GFP-pp150 in HeLa cells 
fixed with paraformaldehyde and stained with the nuclear stain DAPI. 
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Figure 8 Subcellular localization of GFP-pp150 and RFP-pp71 in HeLa cells fixed with 
paraformaldehyde and stained with the nuclear stain DAPI; A- DAPI Stain; B- GFP-
pp150; C- RFP-pp71. 
 
 
 
 
 
 
 
 
 
 
 
Figure 9 Subcellular localization composite of GFP-pp150 and RFP-pp71 in HeLa cells 
fixed with paraformaldehyde and stained with the nuclear stain DAPI. 
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Figure 10 Subcellular localization of CFP-pp65, GFP-pp28, and RFP-pp71 in HeLa cells 
fixed with paraformaldehyde and stained with the nuclear stain DAPI; A- DAPI Stain; B- 
CFP-pp65; C- GFP-pp28; D- RFP-pp71. 
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Figure 11 Subcellular localization composite of CFP-pp65, GFP-pp28, and RFP-pp71 in 
HeLa cells fixed with paraformaldehyde and stained with the nuclear stain DAPI. 
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Tegument Protein Subcellular Localization in Live-Cell Imaged Cells without a Nuclear 
Stain 
 
 Based on the confocal scan images of the paraformaldehyde fixed cells that were 
expressing each of the tegument proteins (pp65, pp71, pp150, and pp28), it was difficult 
to definitively determine where the tegument proteins in the analysis were localizing 
within HeLa cells.  Therefore, live-cell confocal imaging scans were taken 24 hours post-
transfection to acquire better confocal images and negate any artifacts that could have 
occurred during the fixation procedure or from the DAPI stain.  Initially, live-cell 
imaging was performed with the absence of any nuclear stain to act as a control and 
account for any effects that a DNA stain may have on the subcellular localization of the 
tegument proteins. 
 Figure 12 is a representative live-cell confocal scan of HeLa cells that were 
transfected with pp65, pp150, and pp71 plasmids together.  Even without the presence of 
a nuclear stain, the subcellular localization patterns of these tegument proteins can be 
determined.  Pp65 (Figure 12A) appears to localize to the cytoplasm of the cell outlining 
the nucleus of the cell, which was somewhat inferred from the experiments using 
paraformaldehyde fixed HeLa cells.  It can also be seen that pp150 (Figure 12B) and 
pp71 (Figure 12C) appear to localize to the nucleus as confirmed in the 
paraformaldehyde fixed HeLa cells.  However, unlike in the fixed cells, the subcellular 
localization patterns of pp150 and pp71 are more distinct from each other likely due to 
the lack of fixation artifacts.  When the individual images in Figure 12 are merged 
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(Figure 13), it further supports the subcellular localization of the tegument proteins pp65, 
pp150, and pp71. It appears that pp65 is displaying a localization pattern to the cytoplasm 
while pp150 and pp71 display a localization pattern to the nucleus of the HeLa cell. 
 The subcellular localization patterns of pp65, pp150, and pp71 when expressed 
together (Figures 12 and 13) are identical to those observed when the tegument proteins 
are expressed individually in HeLa cells in the absence of a nuclear stain (Figure 14).  
Furthermore, HeLa cells transfected with the pp28 expression plasmid by itself points to 
the subcellular localization of pp28 occurring within the cytoplasm of the cell 
surrounding the nucleus (Figure 15).  This signifies that the fixation artifacts in the 
paraformaldehyde fixed HeLa cells could have impaired the true localization pattern of 
pp28 from being observed.  The subcellular localization of pp28 is further examined 
below. 
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Figure 12 Subcellular localization of CFP-pp65, GFP-pp150, and RFP-pp71 in HeLa 
cells using live-cell imaging with no nuclear stain; A- CFP-pp65; B- GFP-pp150; C- 
RFP-pp71. 
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Figure 13 Subcellular localization of CFP-pp65, GFP-pp150, and RFP-pp71 in HeLa 
cells using live-cell imaging with no nuclear stain. 
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Figure 14 Subcellular localization of CFP-pp65, GFP-pp150, and RFP-pp71 when 
transfected individually in HeLa cells using live-cell imaging with no nuclear stain; A- 
CFP-pp65; B- GFP-pp150; C- RFP-pp71. 
 
Figure 15 Subcellular localization of GFP-pp28 in HeLa cells using live-cell imaging 
with no nuclear stain. 
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Tegument Protein Subcellular Localization in Live-Cell Imaged Cells with Hoechst 
33342 Stain 
 
 Once the subcellular localization of the HCMV proteins (pp65, pp71, pp150, and 
pp28) was determined in the absence of a nuclear stain, a similar procedure was 
performed with the inclusion of a nuclear stain to verify earlier results and definitively 
conclude the subcellular localization patterns of these tegument proteins.  Thus, live-cell 
confocal imaging scans were taken 24 hours post-transfection of HeLa cells with the 
tegument-fluorescent protein fusion plasmids.  Just prior to the confocal imaging, the 
transfected HeLa cells were incubated the nuclear Hoechst 33342 stain.  Hoechst 33342 
stain was used instead of DAPI, because it is well suited for live-cell imaging.  
Furthermore, it can cross cellular membranes easier due to its greater lipophilic nature 
than DAPI. 
 The subcellular localization of pp65, pp150, and pp71 when expressed in HeLa 
cells as fluorescent protein fusion and then stained with the Hoechst 33342 nuclear stain  
were observed via live-cell confocal microscopy (Figure 16).  Based on the location of 
the nucleus labeled with the Hoechst 33342 stain, it can be seen that the preliminary 
results obtained in the absence of the Hoechst 33342 stain are confirmed.  Pp65 (Figure 
16B) localizes to the cytoplasm of the cell, while pp150 and pp71 (Figure 16 C/D 
respectively) localize to the nucleus of the host cell.  Furthermore, it can be seen that the 
Hoechst 33342 stain did not affect the subcellular localization of either of the tegument 
proteins when compared to Figures 12 and 13 lacking the nuclear stain.  The localization 
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of these tegument proteins is even more vivid in the composite image in Figure 17.  
Further support to these localization patterns of the tegument proteins can be seen in 
Figures 18 and 19 with Figure 18 displaying each individual confocal scan channel and 
Figure 19 corresponding to the composite image. 
 The localization patterns observed in Figures 16-19 are further supported by 
Figures 20-25 in which each expression plasmid was transfected into HeLa cells 
individually, which were then incubated with the Hoechst 33342 nuclear stain.  It can be 
seen in Figures 20-25 that pp71 and pp150 do in fact localize to the nucleus, while pp65 
localizes to the cytoplasm of the cell after transfection. 
 Additionally, the subcellular localization of pp28 was determined when expressed 
by itself in HeLa cells that were incubated with the Hoechst 33342 nuclear stain (Figure 
26 and 27).  The confocal microscopy images confirm the results obtained without the 
nuclear stain (Figure 15) in that pp28 is found in the cytoplasm of the host cell.  Pp28 
was not expressed along with other any of the tegument proteins with the nuclear stain, 
because it was felt that the localization of it would not change as seen when pp65, pp150, 
and pp71 were expressed into HeLa cells together. 
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Figure 16 Subcellular localization of CFP-pp65, GFP-pp150, and RFP-pp71 in HeLa 
cells using live-cell imaging stained with the nuclear stain Hoechst 33342; A- Hoechst 
33342 Stain; B- CFP-pp65; C- GFP-pp150; D- RFP-pp71. 
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Figure 17 Subcellular localization composite of CFP-pp65, GFP-pp150, and RFP-pp71 in 
HeLa cells using live-cell imaging stained with the nuclear stain Hoechst 33342. 
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Figure 18 Subcellular localization of CFP-pp65, GFP-pp150, and RFP-pp71 in HeLa 
cells using live-cell imaging stained with the nuclear stain Hoechst 33342; A- Hoechst 
33342 Stain; B- CFP-pp65; C- GFP-pp150; D- RFP-pp71. 
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Figure 19 Subcellular localization composite of CFP-pp65, GFP-pp150, and RFP-pp71 in 
HeLa cells using live-cell imaging stained with the nuclear stain Hoechst 33342. 
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Figure 20 Subcellular localization of RFP-pp71 in HeLa cells using live-cell imaging 
stained with the nuclear stain Hoechst 33342; A- Hoechst 33342 Stain; B- RFP-pp71. 
 
Figure 21 Subcellular localization composite of RFP-pp71 in HeLa cells using live-cell 
imaging stained with the nuclear stain Hoechst 33342. 
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Figure 22 Subcellular localization of CFP-pp65 in HeLa cells using live-cell imaging 
stained with the nuclear stain Hoechst 33342; A- Hoechst 33342 Stain; B- CFP-pp65. 
 
Figure 23 Subcellular localization composite of CFP-pp65 in HeLa cells using live-cell 
imaging stained with the nuclear stain Hoechst 33342. 
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Figure 24 Subcellular localization of GFP-pp150 in HeLa cells using live-cell imaging 
stained with the nuclear stain Hoechst 33342; A- Hoechst 33342 Stain; B- GFP-pp150. 
 
Figure 25 Subcellular localization composite of GFP-pp150 in HeLa cells using live-cell 
imaging stained with the nuclear stain Hoechst 33342. 
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Figure 26 Subcellular localization of GFP-pp28 in HeLa cells using live-cell imaging 
stained with the nuclear stain Hoechst 33342; A- Hoechst 33342 Stain; B- GFP-pp28. 
 
Figure 27 Subcellular localization composite of GFP-pp28 in HeLa cells using live-cell 
imaging stained with the nuclear stain Hoechst 33342. 
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Discussion 
 
 The goal of this study was to determine the subcellular localization of several of 
the major tegument proteins (pp65, pp71, pp150, and pp28) of the HCMV when 
expressed in HeLa cells as fluorescent protein fusions, which may mimic the early stage 
of viral infection before the virus begins replication.  It was demonstrated that pp65 and 
pp28 both localize to the cytoplasm, while pp150 and pp28 both display a nuclear 
localization within the host cell. 
 It was observed in paraformaldehyde fixed HeLa cells that the subcellular 
localization patterns identified and their interpretations were supported definitively in the 
live-cell imaging experiments, which presented a clear image of where each tegument 
proteins localizes within the cell.  This was especially true of pp150 and pp71, which are 
clearly seen to localize to the nucleus.  However, it was more difficult to determine the 
localization patterns of pp65 and pp28.  For example, Figures 10 and 11 indicate that 
pp65 and pp28 could potentially localize to the nucleus of the host cell.  However, the 
location of the nucleus as identified in Figure 10A with the DAPI stain is not well 
defined.   Furthermore, it appears that there could be two adjacent cells next to each other 
that could have potentially been lysed during the fixation protocol with paraformaldehyde 
based on the signals in Figure 10.  It is not possible to definitively state the localization of 
either tegument protein pp65 or pp28 in the paraformaldehyde fixed HeLa cell confocal 
scan images.  Thus, the paraformaldehyde fixed HeLa cells were likely altered in the 
fixation protocol, and some of the fluorescence signal could be attributable to fixation 
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artifacts.  Another possibility in not being able to definitively identify the localization 
patterns of either tegument protein in the paraformaldehyde fixation experiment is due to 
the quality of the DAPI mounting medium that was used.  The DAPI mounting medium 
had passed its expiration date, which could potentially have affected its ability to bind to 
nuclear DNA.  An excellent example of this can be seen in Figure 10A and Figure 11. 
 However, the localization pattern of the tegument proteins (pp65, pp71, pp150, 
and pp28) were fully elucidated in the live-cell imaging experiments in both the absence 
of a nuclear counterstain (Figures 12 to 15) and in the presence of a DNA stain (Figures 
16 to 27).  In the clearest images (Figure 16, 17, 26 and 27) it can be noted that both 
pp150 and pp71 localize to the nucleus of the host cell, while pp65 and pp28 localize to 
the cytoplasm of the host cell.  Additionally, it can be seen that none of the tegument 
proteins appears to affect the subcellular localization of another.  Similarly, neither 
tegument protein is essential for the subcellular localization pattern of another.  This 
contradicts the results of earlier experiments using the DAPI nuclear stain with 
paraformaldehyde fixed cells in the Pizzorno laboratory, which suggested that the 
localization of pp150 is dependent on whether or not pp71 is present (M. Pizzorno, 
personal communication).  It was seen in these previous experiments that pp150 localized 
to the nucleus only when co-transfected with pp71.  The observation that pp150 localized 
to the nucleus only in the presence of pp71 could have been due to the fixation procedure 
or the potential for DAPI to bind at a lower affinity to RNA in the cytoplasm.  
Nonetheless, the live-cell imaging experiment appears to be a more accurate way of 
determining the localization of these proteins than using cells fixed with 
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paraformaldehyde, since the localization patterns are not confounded by fixation or 
staining artifacts that the paraformaldehyde or DAPI stain may cause.  Additionally, the 
live-cell confocal scans yielded a better representative figure of the entire cell and 
nucleus, which subsequently allowed for easier analysis and interpretation. 
 There are several significant implications that arise from the identification of the 
subcellular localization patterns of the HCMV tegument proteins in these experiments.  
The first is that the localization patterns of pp71, pp150, and pp28 is similar to what is 
seen in natural HCMV infections in both fixed and live-cell imaging experiments 
(33,39,40,41).  This also supports a strong correlation to the localization pattern of these 
tegument proteins and their known function during natural HCMV infections as 
hypothesized.  Pp71 localized subcellularly to the nucleus as seen in natural HCMV 
infections due to its role in transactivating transcription of the major immediate-early 
gene (26).  Pp150 localized subcellularly to the nucleus, since it is necessary to 
incorporate nucleocapsids into virus particles but is not required in nucleocapsid 
assembly itself (16).  pp28, by comparison, localized subcellularly to various cytoplasmic 
compartments within the cell as seen in natural HCMV infections due to its essential role 
in the production of viral progeny at the site of final envelopment, which occurs in the 
cytoplasm of the cell (32).  Furthermore, since the subcellular localization patterns of 
these three tegument proteins portrayed similar patterns of localization as what is seen in 
normal HCMV infections with the entire virion being present, it can be concluded that no 
other viral protein, such as another tegument protein or one of the capsid proteins, is 
necessary for the correct subcellular localization of these three tegument proteins. 
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 The most significant piece of information that can be drawn from this experiment, 
though, concerns that subcellular localization pattern that was observed for pp65.  In the 
early stage of a normal HCMV infection, pp65 tends to independently migrate to the 
nucleoli of the cell (34).  This localization to the nucleoli suggests a functional 
relationship between the localization of pp65 and the development of the lytic cycle of 
HCMV (34).  However, pp65 begins to migrate to the cytoplasm 48 hours into the lytic 
cycle with nuclear pore complex becoming devoid of the protein (35).  In accordance 
with previous experiments, it was hypothesized that pp65 would subcellularly localize to 
the nucleus of the cell, since the localization pattern of the tegument proteins were being 
assessed 36 hours post-transfection for the paraformaldehyde fixation experiment and 24 
hours post-transfection for the live-cell imaging experiments.  However, it can clearly be 
seen that pp65, particularly in Figures 16-19, localizes to the cytoplasm of the transfected 
HeLa cells. 
 The observed localization pattern of pp65, which is the major tegument protein 
involved in immune evasion of the host cell, in this experiment in transfected HeLa cells 
could result in a breakthrough in the development of a better targeted and effective, novel 
antiviral treatment of HCMV infections, especially in immunocompromised individuals.  
This localization pattern suggests that something else in the HCMV virion is crucial for 
pp65 to localize to the nucleus of a host cell in the early stages of infection.  Moreover, 
the localization of pp65 to the nucleoli in the early stages of infection suggests a 
functional relationship between the localization of pp65 and the development of the lytic 
cycle of HCMV (24).  This implies that if a novel, antiviral treatment could target the 
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other molecule in the HCMV virion that is required to assist pp65 to get into the nucleus 
of the host cell, HCMV infections and its devastating effects, especially in 
immunocompromised individuals, could be alleviated.  This new data suggests that a 
potential effective, novel, antiviral treatment for HCMV infections could be synthesized 
from inhibiting the localization of pp65 to the nucleus of the cell in the early stages of 
infection. 
 The results that pp65 does not localize to the nucleus are interesting, since it is 
known that pp65 has a bipartite nuclear localization signal (45).  This implies that the 
mechanism by which the other molecule within the HCMV virion that is necessary for 
pp65 nuclear localization during the initial stages of the lytic infection is to expose the 
pp65 nuclear localization signal.  It is known that proteins or other molecules with 
nuclear localization signals do not localize to the nucleus until the signal is exposed and 
recognized by an importin protein.  Thus, the other molecule within the HVMC virion 
may bind to pp65, which yields a conformational change in pp65, thereby, exposing its 
nuclear localization signal to imporitn proteins during the early stages of the lytic cycle. 
 There are other possibilities as to why pp65 subcellularly localized to the 
cytoplasm instead of the nucleus in HeLa cells.  One of which relates to the fact that 
nucleolar accumulation of pp65 is prominent only in G1 and G1/S phases of the cell-
cycle, while it is very poor in S and G2/M phases of the cell-cycle (24).  It is highly 
unlikely that the HeLa cells would not enter the G1 and G1/S phases of the cell-cycle 
post-transfection.  Another possibility is that HeLa cells are not a differentiated 
(permissive) cell type.  Typically, only HCMV is able to produce a lytic infection in 
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differentiated cell types.  It is known in undifferentiated cell types that transcription from 
the major immediate early promoter is repressed by differentiation-dependent 
transcriptional repressors and co-repressors, which impart on the major immediate early 
promoter an overall repressive chromatin structure (46).  This likely had no effect on the 
observed subcellular localization of pp65 to the cytoplasm, since no major immediate-
early promoter was present. 
 There are several studies that could be conducted to build upon the information 
obtained here.  One could perform a time-lapse study for a normal HCMV infection with 
only the tegument proteins being transfected into both undifferentiated and differentiated 
cells.  Additionally, tegument proteins along with virus could be transfected into both 
undifferentiated and differentiated cells for a comparison between cell type and how the 
localization patterns of the tegument proteins are similar/different to transfections 
involving only tegument proteins.  Additionally, initial steps could be used to identify 
any HCMV molecule that is essential for the localization subcellularly of pp65 to the 
nucleus of the cell in the early stages of viral infection.  Once this molecule is identified, 
a novel, antiviral treatment could be synthesized to target it and inhibit the localization of 
pp65 to the nucleus in the early stages of infection, which is essential for the 
establishment of the lytic phase of the viral life cycle in HCMV. 
 The subcellular localization of several HCMV tegument proteins mimicking the 
early stages of a normal viral infection was determined.  It can be seen that pp150 and 
pp71 localize subcellularly to the nucleus post-transfection, while pp28 localizes 
subcellularly to the cytoplasm post-transfection.  These results agree with what is seen in 
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a normal HCMV infection, and suggests a strong correlation between localization and 
function.  Pp65 by comparison was identified to localize subcellularly to the cytoplasm, 
which is not what occurs normally in the early stages of a HCMV infection.  This 
suggests that a molecule within the HCMV virion is essential to getting pp65 into the 
nucleus of the host cell post-transfection.  Thus, this molecule could potentially be 
targeted for the development and synthesis of an effective novel, antiviral treatment of 
HCMV infections that cause significant morbidity and mortality in immunocompromised 
individuals. 
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Appendix 
 
Fluorescently labeled HCMV tegument protein constructs. 
 
 
 
 
